Avadel Pharmaceuticals PLC (FRA:AWK)

€ 11.6 0 (0%) Market Cap: 1.12 Bil Enterprise Value: 1.05 Bil PE Ratio: 0 PB Ratio: 20.33 GF Score: 39/100

Q2 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 08, 2024

€15.4 (+1.32%)

Earnings
Q1 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript
May 08, 2024

€15.58 (-7.92%)

Earnings
Q3 2023 Avadel Pharmaceuticals PLC Earnings Call Transcript
Nov 08, 2023

€9.45 (-2.07%)

Earnings
Q2 2023 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 09, 2023

€12 (+1.69%)

Earnings
Avadel Pharmaceuticals PLC Commercial Day Transcript
Jun 29, 2023
Avadel Pharmaceuticals PLC at Jefferies Healthcare Conference Transcript
Jun 08, 2023
Avadel Pharmaceuticals PLC Business Update Transcript
May 01, 2023
Avadel Pharmaceuticals PLC at Needham Healthcare Conference (Virtual) Transcript
Apr 17, 2023
Q4 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript
Mar 30, 2023

€7.6 (-7.88%)

Earnings
Q3 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript
Nov 09, 2022

€6 (-2.44%)

Earnings
Q2 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 09, 2022

€6 (+6.19%)

Earnings
Avadel Pharmaceuticals PLC Provides Corporate Update Transcript
Jun 30, 2022
Q1 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript
May 09, 2022

€3.8 (-5.94%)

Earnings
Avadel Pharmaceuticals PLC at Needham Healthcare Conference Transcript
Apr 11, 2022
Avadel Pharmaceuticals PLC at Stifel CNS Days (Virtual) Transcript
Mar 29, 2022
Avadel Pharmaceuticals PLC at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 17, 2022
Q4 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript
Mar 17, 2022

€6.2 (+0.81%)

Earnings
Avadel Pharmaceuticals PLC at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022
Avadel Pharmaceuticals PLC at Evercore ISI HealthCONx Virtual Conference Transcript
Dec 01, 2021
Q3 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript
Nov 08, 2021

€8.8 (+1.15%)

Earnings
Avadel Pharmaceuticals PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Q2 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 09, 2021

€6.55 (+4.80%)

Earnings
Avadel Pharmaceuticals PLC at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Jul 14, 2021
Avadel Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript
Jun 01, 2021
Q1 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript
May 10, 2021

€6.55 (+3.15%)

Earnings
Q4 2020 Avadel Pharmaceuticals PLC Earnings Call Transcript
Mar 09, 2021

€6.2 (-6.77%)

Earnings
Avadel Pharmaceuticals PLC at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 24, 2021
Avadel Pharmaceuticals PLC at H C Wainwright BioConnect Conference (Virtual) Transcript
Jan 11, 2021
Avadel Pharmaceuticals PLC at Evercore ISI HealthCONx Conference Transcript
Dec 03, 2020
Q3 2020 Avadel Pharmaceuticals PLC Earnings Call Transcript
Nov 09, 2020

€4.42 (-5.56%)

Earnings
Q2 2020 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 10, 2020

€6.9 (-1.43%)

Earnings
Avadel Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2020
Q1 2020 Avadel Pharmaceuticals PLC Earnings Call Transcript
May 11, 2020

€8.45 (+1.20%)

Earnings
Avadel Pharmaceuticals PLC REST-ON Phase 3 Trial Data Call Transcript
Apr 27, 2020
Q4 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript
Mar 12, 2020

€6.9 (-6.76%)

Earnings
Q3 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript
Nov 12, 2019

€4.34 (+1.40%)

Earnings
Avadel Pharmaceuticals PLC at Ladenburg Thalmann Healthcare Conference Transcript
Sep 24, 2019
Avadel Pharmaceuticals PLC Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study Transcript
Sep 23, 2019
Q2 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript
Aug 09, 2019

€1.94 (+2.11%)

Earnings
Q1 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript
May 08, 2019

€1.04 (-6.31%)

Earnings
Q4 2018 Avadel Pharmaceuticals PLC Earnings Call Transcript
Mar 15, 2019

€1.65 (-3.52%)

Earnings

Q3 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript

Nov 08, 2021 / 01:30PM GMT

Release Date Price: €8.8 (+1.15%)

Transcript 10-Q8-K

Operator

Greetings, and welcome to the Avadel Pharmaceuticals Third Quarter 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Courtney Turiano. Thank you. You may begin.

Courtney Turiano

Stern Investor Relations, Inc. - Client Lead

Good morning, and thank you for joining us on our conference call. This morning, we issued our press release providing a corporate update and financial results for the quarter ended September 30, 2021. The release can be accessed on our website, www.avadel.com.

As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include risks that products in the development

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.